PNC Financial Services Group
SLXP

PNC Financial Services Group’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

PNC Financial Services Group’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1,101
Closed -$191K – 4898
2015
Q1 		$191K Buy
1,101
+174
+19% +$25.5K ﹤0.01% 2267
2014
Q4 		$107K Sell
927
-2,985
-76% -$362K ﹤0.01% 2437
2014
Q3 		$610K Buy
3,912
+1,687
+76% +$245K ﹤0.01% 1358
2014
Q2 		$273K Buy
2,225
+98
+5% +$10.8K ﹤0.01% 1754
2014
Q1 		$220K Sell
2,127
-1,201
-36% -$123K ﹤0.01% 1848
2013
Q4 		$299K Sell
3,328
-823
-20% -$65.6K ﹤0.01% 1674
2013
Q3 		$278K Buy
4,151
+693
+20% +$47.8K ﹤0.01% 1685
2013
Q2 		$229K Buy
+3,458
New +$198K ﹤0.01% 1710

Other funds holding SLXP

MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

PNC Financial Services Group's SLXP Position: Q2 2015 in Review

PNC Financial Services Group sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 1,101 shares — an estimated $191K sold.

PNC Financial Services Group first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $610K in Q3 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • PNC Financial Services Group reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • PNC Financial Services Group sold 1,101 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $191K.
  • PNC Financial Services Group first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
  • PNC Financial Services Group's SALIX PHARMACEUTICALS LTD DEL position peaked at $610K in Q3 2014.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on PNC Financial Services Group's 13F filing for Q2 2015, filed 5 Aug 2015.